Suptavumab

DB12759InvestigationalProtein Based Therapies

Suptavumab has been used in trials studying the treatment and basic science of Respiratory Syncytial Virus Infections.

Mechanism
Curator reviewed
Code names
REGN2222

Resolves to

Compound
UNIIA0ZE931055CAS1629615-23-1
Targets
P03420F

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Suptavumab, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In